Localized prostate cancer with intermediate- or high-risk features treated with combined external beam radiotherapy and iodine-125 seed brachytherapy
To access this article, please choose from the options below
This work was performed by Brazilian Institute of Oncology (IBO)—Radioterapia Botafogo, Pontifical Catholic University of Rio de Janeiro(PUCRJ), and Clementino Fraga Filho University Hospital of Rio de Janeiro Federal University. IBO was the sponsor for the expenses involved in the edition of this article.
PII: S1538-4721(10)00286-2
doi:10.1016/j.brachy.2009.07.011
© 2010 American Brachytherapy Society. Published by Elsevier Inc. All rights reserved.
